Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Benjamin Berger

Showing results (1-10 of 68) with videos related to

Pageof 7
Sort By:
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|June 7, 2021
Pharmacokinetic and pharmacodynamic interactions between daridorexant, a dual orexin receptor antagonist, and citalopram in healthy subjectsBenjamin Berger, Rüdiger Kornberger, Jasper Dingemanse
The International Journal of Neuroscience|April 8, 2020
Glioblastoma evolving within 10 days following unremarkable computer tomography of the brain: a case reportNils Schröter, Niklas Lützen, Soroush Doostkam, et al.
The International Journal of Neuroscience|February 19, 2016
Absent anti-N-methyl-D-aspartate receptor NR1a antibodies in herpes simplex virus encephalitis and varicella zoster virus infectionsBenjamin Berger, Maximilian Pytlik, Tilman Hottenrott, et al.
Journal of Clinical Pharmacology|February 9, 2020
Impact of the Selective Orexin-1 Receptor Antagonist ACT-539313 on the Pharmacokinetics of the CYP3A Probe Drug Midazolam in Healthy Male SubjectsBenjamin Berger, Priska Kaufmann, Annelize Koch, et al.
Neuroradiology|March 29, 2020
"Negative T2 shine through" in patients with hyperglycemia and seizures: a frequently overlooked MRI patternHorst Urbach, Benjamin Berger, Laszlo Solymosi, et al.
Clinical and Translational Science|June 14, 2021
Pharmacokinetics of daridorexant, a dual orexin receptor antagonist, are not affected by renal impairmentBenjamin Berger, Clemens Muehlan, Gernot Klein, et al.
BMC Neurology|January 11, 2017
Screening for onconeural antibodies in neuromyelitis optica spectrum disordersBenjamin Berger, Tilman Hottenrott, Sebastian Rauer, et al.
Journal of Critical Care|December 17, 2013
Epidemiologic features, risk factors, and outcome of sepsis in stroke patients treated on a neurologic intensive care unitBenjamin Berger, Christoph Gumbinger, Thorsten Steiner, et al.
Journal of Neuroimmunology|May 29, 2016
Screening for anti-titin antibodies in patients with various paraneoplastic neurological syndromesBenjamin Berger, Oliver Stich, Siegfried Labeit, et al.
Journal of the Neurological Sciences|March 12, 2014
Corticosteroid-responsive torticollis as a presenting symptom of multiple sclerosisBenjamin Berger, Michel Rijntjes, Lena Stehlin, et al.
Pageof 7

Showing results (1-10 of 68) with videos related to

Sort By:
Pageof 7
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|June 7, 2021
Pharmacokinetic and pharmacodynamic interactions between daridorexant, a dual orexin receptor antagonist, and citalopram in healthy subjectsBenjamin Berger, Rüdiger Kornberger, Jasper Dingemanse
The International Journal of Neuroscience|April 8, 2020
Glioblastoma evolving within 10 days following unremarkable computer tomography of the brain: a case reportNils Schröter, Niklas Lützen, Soroush Doostkam, et al.
The International Journal of Neuroscience|February 19, 2016
Absent anti-N-methyl-D-aspartate receptor NR1a antibodies in herpes simplex virus encephalitis and varicella zoster virus infectionsBenjamin Berger, Maximilian Pytlik, Tilman Hottenrott, et al.
Journal of Clinical Pharmacology|February 9, 2020
Impact of the Selective Orexin-1 Receptor Antagonist ACT-539313 on the Pharmacokinetics of the CYP3A Probe Drug Midazolam in Healthy Male SubjectsBenjamin Berger, Priska Kaufmann, Annelize Koch, et al.
Neuroradiology|March 29, 2020
"Negative T2 shine through" in patients with hyperglycemia and seizures: a frequently overlooked MRI patternHorst Urbach, Benjamin Berger, Laszlo Solymosi, et al.
Clinical and Translational Science|June 14, 2021
Pharmacokinetics of daridorexant, a dual orexin receptor antagonist, are not affected by renal impairmentBenjamin Berger, Clemens Muehlan, Gernot Klein, et al.
BMC Neurology|January 11, 2017
Screening for onconeural antibodies in neuromyelitis optica spectrum disordersBenjamin Berger, Tilman Hottenrott, Sebastian Rauer, et al.
Journal of Critical Care|December 17, 2013
Epidemiologic features, risk factors, and outcome of sepsis in stroke patients treated on a neurologic intensive care unitBenjamin Berger, Christoph Gumbinger, Thorsten Steiner, et al.
Journal of Neuroimmunology|May 29, 2016
Screening for anti-titin antibodies in patients with various paraneoplastic neurological syndromesBenjamin Berger, Oliver Stich, Siegfried Labeit, et al.
Journal of the Neurological Sciences|March 12, 2014
Corticosteroid-responsive torticollis as a presenting symptom of multiple sclerosisBenjamin Berger, Michel Rijntjes, Lena Stehlin, et al.
Pageof 7